Renée S. Martin - Publications, H-index & Citations

Renée S. Martin

university of pennsylvania

20H指数

58论文数

1.5K被引数

收录论文 19

发表时间

Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson's Disease

JOURNAL OF PARKINSONS DISEASE

IF5

2024-08-22

OAAI

Eijsvogel, Pepijn P. N. M.; Borghans, Laura G. J. M.; Prins, Samantha; Moss, Laurence; van Kraaij, Sebastiaan J. W.; van Brummelen, Emilie; Klaassen, Erica; Martin, Renee S.; Bautista, Edgar; Ford, Anthony P.; Kremer, Philip H. C.; Groeneveld, Geert Jan; Vargas, Gabriel A.

Effects on cerebral blood flow after single doses of the β2 agonist, clenbuterol, in healthy volunteers and patients with mild cognitive impairment or Parkinson's disease

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2024-07-02

PREAI

Lodeweyckx, Thomas; de Hoon, Jan; Van Laere, Koen; Bautista, Edgar; Rizzo, Gaia; Bishop, Courtney; Rabiner, Eugenii; Martin, Renee S.; Ford, Anthony; Vargas, Gabriel

Association of a Surgical Task During Training With Team Skill Acquisition Among Surgical Residents The Missing Piece in Multidisciplinary Team Training

JAMA SURGERY

IF14.9

2017-09-01

OAAI

Sparks, Jessica L.; Crouch, Dustin L.; Sobba, Kathryn; Evans, Douglas; Zhang, Jing; Johnson, James E.; Saunders, Ian; Thomas, John; Bodin, Sarah; Tonidandel, Ashley; Carter, Jeff; Westcott, Carl; Martin, Shayn; Hildreth, Amy

EXPLORATORY RESULTS FROM THE BLISS AND ILLUMINATE TRIALS SUPPORT THE DESIGN OF THE CHABLIS-SC1 TRIAL, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BLISIBIMOD ADMINISTRATION IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Merrill, J. T.; Strand, V.; Hislop, C.; Gangal, M.; Martin, R. S.; Kalunian, K. C.

Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser Blisibimod用于治疗系统性红斑狼疮: 通过试验使您变得更明智

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2016-04-07

PREAI

Scheinberg, Morton A.; Hislop, Colin M.; Martin, Renee S.

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-09-01

124

PREAI

Furie, R. A.; Leon, G.; Thomas, M.; Petri, M. A.; Chu, A. D.; Hislop, C.; Martin, R. S.; Scheinberg, M. A.

Oligomeric Properties of Survival Motor Neuron.Gemin2 Complexes

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2015-08-01

OAAI

Gupta, Kushol; Martin, Renee; Sharp, Robert; Sarachan, Kathryn L.; Ninan, Nisha S.; Van Duyne, Gregory D.

EFFECTS OF BLISIBIMOD, AN INHIBITOR OF B CELL ACTIVATING FACTOR, ON PATIENT REPORTED OUTCOMES AND DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-06-01

PREAI

Petri, M.; Martin, R. S.; Hislop, C.; Scheinberg, M. A.; Furie, R. A.

EFFECTS OF BLISIBIMOD ON SERUM IMMUNOGLOBULINS AND INFECTION RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM THE PLACEBO-CONTROLLED PEARL-SC AND OPEN-LABEL EXTENSION STUDIES

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2014-06-01

PREAI

Richard, F. A.; Scheinberg, M. A.; Thomas, M.; Chu, A. D.; Martin, R. S.; Hislop, C.; Petri, M.

EFFECTS OF CHRONIC TREATMENT WITH SUBCUTANEOUS BLISIBIMOD ON RENAL AND INFLAMMATION BIOMARKERS IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN PHASE 2 PEARL-SC AND OPEN-LABEL EXTENSION STUDIES

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2014-06-01

PREAI

Richard, F. A.; Scheinberg, M. A.; Thomas, M.; Chu, A. D.; Hislop, C.; Martin, R. S.; Petri, M.

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2010-06-25

120

OAAI

Gever, Joel R.; Soto, Rothschild; Henningsen, Robert A.; Martin, Renee S.; Hackos, David H.; Panicker, Sandip; Rubas, Werner; Oglesby, Ian B.; Dillon, Michael P.; Milla, Marcos E.; Burnstock, Geoffrey; Ford, Anthony P. D. W.

Characterization of human recombinant α2A-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-02-02

OAAI

MacLennan, SJ; Reynen, PH; Martin, RS; Eglen, RM; Martin, GR

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-30

OAAI

Martin, RS; Luong, LA; Welsh, NJ; Eglen, RM; Martin, GR; MacLennan, SJ